Search CAHR Abstracts

EPIDEMIOLOGY AND PUBLIC HEALTH / ÉPIDÉMIOLOGIE ET SANTÉ PUBLIQUE
ORAL PRESENTATIONS / PRÉSENTATIONS ORALES

RISK FACTORS FOR HIV INFECTION AMONG INJECTION DRUG USERS AND MEN WHO HAVE SEX WITH MEN

[301] RISK FACTORS FOR HIV AND HCV PREVALENCE AND INCIDENCE AMONG YOUNG INJECTION DRUG USERS IN A CANADIAN CITY COPING WITH AN EPIDEMIC
Cari L Miller, Patricia Spittal, Nancy LaLiberte, Kathy Li, Micheal O’Shaughnessy, Martin T Schechter

[302] RISKY SEXUAL BEHAVIORS AMONG FEMALE INJECTION DRUG USERS WITH HIGH HIV PREVALENCE: IMPLICATIONS FOR HIV AND STD CONTROL
Mark W Tyndall, P Spittal, N Laliberte, K Li, MV O’Shaughnessy, MT Schechter
Vancouver Injection Drug User Study, BC Centre for Excellence in HIV/AIDS

[303] WHAT CAN WE LEARN FROM CHRONIC, NON-INFECTED IDUs: SOCIODEMOGRAPHIC CHARACTERISTICS AND FACTORS ASSOCIATED WITH LONG-TERM HIV AND HCV SERONEGATIVITY
Julie Bruneau^1,2, Susan Brogly², François Lamothe¹, Jean Vincelette^1
1Centre de recherche du Centre Hospitalier de l’Université de Montréal; ²Département d’épidémiologie et biostatistiques Université McGill

[304] GENDER-SPECIFIC PREDICTORS OF HIV INFECTION AMONG INJECTION DRUG USERS IN VANCOUVER
PM Spittal^1,2, KJP Craib^1,4, K Li¹, N Laliberte¹, M Tyndall^1,2, E Wood^1,4, MV O’Shaughnessy^1,3, MT Schechter^1,2
1British Columbia Centre for Excellence in HIV/AIDS; ²Department of Health Care & Epidemiology; ³Department of Laboratory Medicine & Pathology; ⁴Faculty of Medicine, University of British Columbia, Vancouver, British Columbia

[305] GENDER DIFFERENCES IN SEXUAL VIOLENCE (SV) EXPERIENCES AND CONSEQUENCES AMONG INJECTION DRUG USERS (IDU)
P Braitstein, K Li, M Tyndall, P Spittal, RS Hogg, MV O’Shaughnessy, MT Schechter
British Columbia Centre for Excellence in HIV/AIDS, St Paul’s Hospital, Vancouver, British Columbia

[306] INCREASE IN UNPROTECTED ANAL INTERCOURSE (UAI) AMONG MEN HAVING SEXUAL RELATIONS WITH OTHER MEN (MSM) PARTICIPATING IN THE OMEGA COHORT STUDY. HAS THIS NORTH AMERICAN WAVE FINALLY REACHED MONTREAL?
Clemon George^4,9, M Alary^4,8, J Otis^1,2, E Demers⁴, R Remis⁵, B Turmel⁷, R LeClerc², R Lavoie³, J Vincelette⁶, R Parent⁸, B Mâsse⁴, the Omega Study Group: Omega Cohort, Montreal, Quebec
¹Université du Québec à Montréal, Département de sexology; ²Coalition des Organismes Communautaire Québécois de lutte contre le sida; ³Action Séro Zéro; ⁴Centre Hospitalier Affilié Universitaire de Québec; ⁵University of Toronto, Department of Public Health Sciences; ⁶Hôpital Saint-Luc, Service d’immunologie; ⁷Direction Générale de Santé Publique;⁸Institut national de Santé Publique du Québec; ⁹Université Laval, Département de médicine sociale et préventive

[307] RISK FACTORS FOR HIV SEROCONVERSION AMONG MEN HAVING SEX WITH MEN (MSM) IN MONTREAL
Michel Alary, Robert S Remis, Joanne Otis, Benoît Mâsse, Bruno Turmel, Roger LeClerc, René Lavoie, Jean Vincelette, Raymond Parent and the Omega Study Group
Omega Cohort, Montréal, Québec

[308] TRENDS IN HIGH-RISK RISK BEHAVIOUR AMONG HOMOSEXUAL MEN PARTICIPATING IN THE AIDSVAX® B/B VACCINE TRIAL IN CANADA: RESULTS TO 24 MONTHS
J Vincelette¹, RS Remis², K Logue^2,3, RS Hogg⁴, B Willoughby⁵, N McLean⁴, JL Roy¹, K Linnen³, M Longhi⁶, V Popovic^6
1Centre hospitalier de l’Université de Montréal, Montreal, Quebec; ²University of Toronto, Toronto, Ontario; ³cascAIDS Inc, Toronto, Ontario; ⁴BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia; ⁵Viron Health, Vancouver, British Columbia; ⁶VaxGen Inc, Brisbane, California